Key facts
- Ayrton Capital LLC filed SCHEDULE 13G/A for PETROS PHARMACEUTICALS, INC. Common Stock, $0.0001 par value (PTPI).
- Disclosed ownership: 6.2%.
- Date of event: 31 Dec 2024.
Ayrton Capital LLC - 31 Dec 2024 SCHEDULE 13G/A Report for PETROS PHARMACEUTICALS, INC. Common Stock, $0.0001 par value (PTPI)
- Filing Manager
- Ayrton Capital LLC
- Reporting Manager
- Ayrton Capital LLC
- Symbol
- PTPI
- Shares outstanding
- 10,606,677 shares
- Disclosed Ownership
- 657,614 shares
- Ownership
- 6.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Feb 2025, 13:44:26 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Key filing fact
Ayrton Capital LLC disclosed 6.2% ownership in PETROS PHARMACEUTICALS, INC. Common Stock, $0.0001 par value (PTPI) on 31 Dec 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Feb 2025, 13:44.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Ayrton Capital LLC | 6.2% | 657,614 | 657,614 | 0 | /s/ Waqas Khatri | Waqas Khatri / Managing Member | |
| Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B | 6.2% | 657,614 | 657,614 | 0 | /s/ Waqas Khatri | Waqas Khatri / Director | |
| Waqas Khatri | 6.2% | 657,614 | 657,614 | 0 | /s/ Waqas Khatri | Waqas Khatri |
CIK / CUSIP context first